BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17263971)

  • 1. The value of intraoperative pentagastrin testing in medullary thyroid cancer.
    Scheuba C; Bieglmayer C; Asari R; Kaczirek K; Izay B; Kaserer K; Niederle B
    Surgery; 2007 Feb; 141(2):166-71; discussion 171-2. PubMed ID: 17263971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
    Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
    Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.
    Weber T; Schilling T; Frank-Raue K; Colombo-Benkmann M; Hinz U; Ziegler R; Klar E
    Surgery; 2001 Dec; 130(6):1044-9. PubMed ID: 11742336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullary thyroid microcarcinoma recommendations for treatment - a single-center experience.
    Scheuba C; Kaserer K; Bieglmayer C; Asari R; Riss P; Drosten R; Niederle B
    Surgery; 2007 Dec; 142(6):1003-10; discussion 1010.e1-3. PubMed ID: 18063088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
    Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative high-dose calcium stimulation test in patients with sporadic medullary thyroid carcinoma is highly accurate in predicting lateral neck metastases.
    De Crea C; Raffaelli M; Milano V; Carrozza C; Zuppi C; Bellantone R; Lombardi CP
    Surgery; 2016 Jan; 159(1):70-6. PubMed ID: 26456123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal.
    Faggiano A; Milone F; Ramundo V; Chiofalo MG; Ventre I; Giannattasio R; Severino R; Lombardi G; Colao A; Pezzullo L
    J Clin Endocrinol Metab; 2010 Sep; 95(9):E32-6. PubMed ID: 20534767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of lateral lymph node metastases in medullary thyroid cancer.
    Machens A; Hauptmann S; Dralle H
    Br J Surg; 2008 May; 95(5):586-91. PubMed ID: 18300267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
    Schott M; Willenberg HS; Sagert C; Nguyen TB; Schinner S; Cohnen M; Cupisti K; Eisenberger CF; Knoefel WT; Scherbaum WA
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioactive iodine treatment in medullary thyroid carcinoma.
    Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
    Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent hypercalcitoninemia in patients with medullary thyroid cancer: a therapeutic approach based on selective venous sampling for calcitonin.
    Medina-Franco H; Herrera MF; López G; Tielve-Campillo M; Sierra M; Lozano-Salazar RR; González O
    Rev Invest Clin; 2001; 53(3):212-7. PubMed ID: 11496707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of sporadic medullary thyroid carcinoma: strategy and outcome.
    Misso C; Calzolari F; Puxeddu E; Lucchini R; Monacelli M; D'Ajello F; Giammartino C; D'Ajello M; Ragusa M; Avenia N
    G Chir; 2008; 29(11-12):475-8. PubMed ID: 19068183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination?
    Machens A; Hauptmann S; Dralle H
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2234-8. PubMed ID: 18364379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
    Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
    Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.
    Machens A; Hoffmann F; Sekulla C; Dralle H
    Endocr Relat Cancer; 2009 Dec; 16(4):1291-8. PubMed ID: 19726541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can measurement of basal calcitonin replace the pentagastrin test?].
    Vestergaard P; Jönsson AL; Christiansen P; Frohnert J
    Ugeskr Laeger; 2008 Oct; 170(41):3238-42. PubMed ID: 18940156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neck management in medullary thyroid carcinoma.
    Oskam IM; Hoebers F; Balm AJ; van Coevorden F; Bais EM; Hart AM; van den Brekel MW
    Eur J Surg Oncol; 2008 Jan; 34(1):71-6. PubMed ID: 17555910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy as guidance for central neck dissection in patients with papillary thyroid carcinoma.
    Roh JL; Park CI
    Cancer; 2008 Oct; 113(7):1527-31. PubMed ID: 18671238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.